Analysts Estimates and Ratings Intellia Therapeutics, Inc.(NASDAQ:NTLA): Cornerstone OnDemand, Inc.(NASDAQ:CSOD)

0
6

Intellia Therapeutics, Inc. (NTLA) will report its next earnings on Mar 13 BMO. The company reported the earnings of $-0.43/Share in the last quarter where the estimated EPS by analysts was $-0.56/share. The difference between the expected and actual EPS was $0.13/share, which represents an Earnings surprise of 23.2%.

Many analysts are providing their Estimated Earnings analysis for Intellia Therapeutics, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $-0.58/share. These analysts have also projected a Low Estimate of $-0.78/share and a High Estimate of $-0.48/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Intellia Therapeutics, Inc. as 7.63 Million. According to these analysts, the Low Revenue Estimate for Intellia Therapeutics, Inc. is 5 Million and the High Revenue Estimate is 10.63 Million. The company had Year Ago Sales of 7.47 Million.

Some buy side analysts are also providing their Analysis on Intellia Therapeutics, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Intellia Therapeutics, Inc. might touch $57.5 high while the Average Price Target and Low price Target is $31.79 and $19 respectively.

Intellia Therapeutics, Inc. closed its last trading session at $16.49 with the loss of -2.06%. The Market Capitalization of the company stands at 723.36 Million. The Company has 52-week high of $32.99 and 52-week low of $11.03. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.94% where SMA50 and SMA200 are 11.71% and -26.45% respectively. The Company Touched its 52-Week High on 09/20/18 and 52-Week Low on 12/24/18.

The Relative Volume of the company is 0.64 and Average Volume (3 months) is 656.82 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -25%. The Return on Equity (ROE) value stands at -30.6%. While it’s Return on Investment (ROI) value is 0%.

While looking at the Stock’s Performance, Intellia Therapeutics, Inc. currently shows a Weekly Performance of 3.93%, where Monthly Performance is 16.02%, Quarterly performance is -2.06%, 6 Months performance is -44.56% and yearly performance percentage is -51.38%. Year to Date performance value (YTD perf) value is 18.32%. The Stock currently has a Weekly Volatility of 5.46% and Monthly Volatility of 5.89%.

Cornerstone OnDemand, Inc. (CSOD) will report its next earnings on Feb 12 AMC. The company reported the earnings of $0.24/Share in the last quarter where the estimated EPS by analysts was $0.23/share. The difference between the expected and actual EPS was $0.01/share, which represents an Earnings surprise of 4.3%.

Many analysts are providing their Estimated Earnings analysis for Cornerstone OnDemand, Inc. and for the current quarter 11 analysts have projected that the stock could give an Average Earnings estimate of $0.19/share. These analysts have also projected a Low Estimate of $0.16/share and a High Estimate of $0.23/share.

In case of Revenue Estimates, 11 analysts have provided their consensus Average Revenue Estimates for Cornerstone OnDemand, Inc. as 135.57 Million. According to these analysts, the Low Revenue Estimate for Cornerstone OnDemand, Inc. is 135.11 Million and the High Revenue Estimate is 136 Million. The company had Year Ago Sales of 133.13 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for CSOD to be 38.5%. They are projecting Next Quarter growth of 58.33%. For the next 5 years, Cornerstone OnDemand, Inc. is expecting Growth of 46.92% per annum, whereas in the past 5 years the growth was 28.38% per annum.

Some buy side analysts are also providing their Analysis on Cornerstone OnDemand, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Cornerstone OnDemand, Inc. might touch $71 high while the Average Price Target and Low price Target is $62.8 and $50 respectively.

Cornerstone OnDemand, Inc. closed its last trading session at $55.77 with the loss of -0.7%. The Market Capitalization of the company stands at 3.27 Billion. The Company has 52-week high of $60.19 and 52-week low of $37.74. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -1.52% where SMA50 and SMA200 are 0.07% and 4.83% respectively. The Company Touched its 52-Week High on 02/12/19 and 52-Week Low on 03/29/18.

The Relative Volume of the company is 1.14 and Average Volume (3 months) is 424.15 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 38.81.

The company shows its Return on Assets (ROA) value of -4%. The Return on Equity (ROE) value stands at -72.4%. While it’s Return on Investment (ROI) value is -3%.

While looking at the Stock’s Performance, Cornerstone OnDemand, Inc. currently shows a Weekly Performance of 2.65%, where Monthly Performance is -7.87%, Quarterly performance is 6.48%, 6 Months performance is -3.92% and yearly performance percentage is 24.34%. Year to Date performance value (YTD perf) value is 9.82%. The Stock currently has a Weekly Volatility of 2.56% and Monthly Volatility of 2.81%.

SHARE